Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

C.L.M. Krieckaert, S.C. Nair, M.T. Nurmohamed, C.J.J. van Dongen, W.F. Lems, F.P.J.G. Lafeber, J.W.J. Bijlsma, H. Koffijberg, G. Wolbink, P.M.J. Welsing

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)361-368
JournalAnnals of the Rheumatic Diseases
Volume74
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Krieckaert, C.L.M. ; Nair, S.C. ; Nurmohamed, M.T. ; van Dongen, C.J.J. ; Lems, W.F. ; Lafeber, F.P.J.G. ; Bijlsma, J.W.J. ; Koffijberg, H. ; Wolbink, G. ; Welsing, P.M.J. / Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects. In: Annals of the Rheumatic Diseases. 2015 ; Vol. 74, No. 2. pp. 361-368.
@article{a6f4fe01a7c84ccc8baa611304408a15,
title = "Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects",
author = "C.L.M. Krieckaert and S.C. Nair and M.T. Nurmohamed and {van Dongen}, C.J.J. and W.F. Lems and F.P.J.G. Lafeber and J.W.J. Bijlsma and H. Koffijberg and G. Wolbink and P.M.J. Welsing",
year = "2015",
doi = "10.1136/annrheumdis-2013-204101",
language = "Undefined/Unknown",
volume = "74",
pages = "361--368",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "2",

}

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects. / Krieckaert, C.L.M.; Nair, S.C.; Nurmohamed, M.T.; van Dongen, C.J.J.; Lems, W.F.; Lafeber, F.P.J.G.; Bijlsma, J.W.J.; Koffijberg, H.; Wolbink, G.; Welsing, P.M.J.

In: Annals of the Rheumatic Diseases, Vol. 74, No. 2, 2015, p. 361-368.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

AU - Krieckaert, C.L.M.

AU - Nair, S.C.

AU - Nurmohamed, M.T.

AU - van Dongen, C.J.J.

AU - Lems, W.F.

AU - Lafeber, F.P.J.G.

AU - Bijlsma, J.W.J.

AU - Koffijberg, H.

AU - Wolbink, G.

AU - Welsing, P.M.J.

PY - 2015

Y1 - 2015

U2 - 10.1136/annrheumdis-2013-204101

DO - 10.1136/annrheumdis-2013-204101

M3 - Article

VL - 74

SP - 361

EP - 368

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 2

ER -